2Michael X. Repka Betty Tung William V. Good Michael Shapiro Antonio Capone Jr John D. Baker Charles C. Barr Dale L. Phelps W. A. J. van HewvenMD John D. Baker,MD, Charles C. Barr,MD, Dale L. Phelps,MD, IV. A. J. van Heuven 张弛（译）.早产儿视网膜病变早期治疗（ETROP）过程中发生视网膜脱离眼的预后[J].美国医学会眼科杂志（中文版）,2006,18(3):169-175. 被引量：5
1Chan-ling T, Halasz P, Stone J, et al.Develoment of retinal vasculature in the cat:Processes and mechanisms. Curr Eye Res,1990,9:459.
2Luna B, Dobson V, Biglan AW. Development of grating acuity in infants with regressed stage 3 retinopathy of prematurity. Invest Ophthalmol Vis Sci,1990,31:2082.
3Berkman RA, Merrill MJ, Reinhold WC,et al. Expression of the vascular permeability factor/ vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest,1993,91:153-159.
4Witmer AN, Blaauwgeers HG, Weich HA, et al. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF -induced retinopathy in monkey. Invest Ophthalmol Vis Sci, 2002, 43:849-857.
5Kendall RL, Thomas KA, Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA,1993,90:10705.
6The Eyetech Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration.Retina,2002,22:143-152.
7Chan-Ling T,Tout S,Hollander H,et al.Vascular change and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci,1992,33:2128-3435.
8Sinicrope FA, Ruan SB, Cleary KR, et al.Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res,1995,55:237-241.
9Hardy P, Dumont I, Bhattacharya M, et al .Oxidants,nitric oxide and prostanoids in the developing ocular vasculature: a basis for ischemic retinopathy. Cardiovasc Res,2000, 47:489-509.
10Terry TL.Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens.Am J Ophthaol,1942,25():203
